"[I]t appears that the statistical significance [of the results] hangs on very few cases of HIV infection," said Treatment Action Group, which in a statement urged "caution in interpreting the findings until more detailed information is available."
Other organizations and members of the scientific community responded to the study results enthusiastically. However, none suggested that the study results signify that a fully effective HIV vaccine is right around the corner.
The Context: More Information on This Study
Still trying to wrap your head around the major findings of this study? Visit TheBody.com's RV144 page for a range of articles and reactions on the RV144 trial and its results, including:
An overview of the study findings and reactions that includes some lesser-known details about the trial, such as the fact that most of the volunteers were not at high risk for HIV, and that the strain of HIV most common in Thailand is not the one that's most common in Europe and the U.S.